Publications
11
Citations
400
Est. group size
—
Recurring co-author estimate
Active years
9
Publishing since 2017
Brennan A. Murphy works in organic and medicinal chemistry, focusing on developing new methods to synthesize complex amino acids and molecular building blocks, as well as designing and screening chemical compounds that inhibit disease-related proteins. Recent work spans the synthesis of specialized amino acids (such as lanthionines) using ring-opening chemistry and the identification of inhibitors for enzymes tied to conditions like viral infection and cancer.
Publication output has been steady but modest over the past decade, averaging about one paper per year.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Synthesis of the <i>tris</i>-Amino Acid Labionin through a Contrasteric Aziridination and Ring-Opening Sequence
Organic Letters · 2025
- Neutral sphingomyelinase 2 inhibitors based on the pyrazolo[1,5-a]pyrimidin-3-amine scaffold
European Journal of Medicinal Chemistry · 2023
- High-Throughput Activity Assay for Screening Inhibitors of the SARS-CoV-2 Mac1 Macrodomain
ACS Chemical Biology · 2021
- High-throughput Activity Assay for Screening Inhibitors of the SARS-CoV-2 Mac1 Macrodomain
bioRxiv (Cold Spring Harbor Laboratory) · 2021
- Scalable Synthesis of Orthogonally Protected β-Methyllanthionines by Indium(III)-Mediated Ring Opening of Aziridines
Organic Letters · 2019
- Organic Letters×2
- Chemical Science×1
- Nature Chemistry×1
- ACS Chemical Biology×1
- Angewandte Chemie International Edition×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile